NRF2-deficient mice undergoing ovariectomy exhibited severe osteopenia, and treatment with dimethyl fumarate, an NRF2 activator used in the clinic, restored NRF2 levels and reduced bone loss in an OP model. The gene discussed is NFE2L2; the disease is Osteopenia.